|
Index of reports
> Cases resulting in death (59)
> Cases with Hyperthyroidism (12)
Below is the selection of adverse event reports related to Micardis (Telmisartan) that includes cases resulting in death where reactions include hyperthyroidism.
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a health professional (non-physician/pharmacist) from France on 2007-04-26
Patient: 83 year old male
Adverse reactions / side effects: Hyperthyroidism
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Temgesic
Administration route: Oral
Kardegic
Administration route: Oral
End date: 2006-06-08
Omeprazole
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Micardis
Administration route: Oral
Indication: Essential Hypertension
End date: 2006-06-08
Nitroderm
Administration route: Topical
End date: 2006-06-18
Hemigoxine Nativelle
Administration route: Oral
End date: 2006-06-08
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a health professional (non-physician/pharmacist) from France on 2007-04-26
Patient: 83 year old male
Adverse reactions / side effects: Congestive Cardiomyopathy, Hyperthyroidism
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Temgesic
Administration route: Oral
Indication: Brain Neoplasm
Kardegic
Administration route: Oral
Indication: Myocardial Infarction
End date: 2006-06-08
Omeprazole
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Micardis
Administration route: Oral
Indication: Essential Hypertension
End date: 2006-06-08
Nitroderm
Administration route: Topical
Indication: Myocardial Infarction
End date: 2006-06-18
Hemigoxine Nativelle
Administration route: Oral
Indication: Myocardial Infarction
End date: 2006-06-08
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a health professional (non-physician/pharmacist) from France on 2007-04-25
Patient: 83 year old male
Adverse reactions / side effects: Hyperthyroidism
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Temgesic
Administration route: Oral
Kardegic
Administration route: Oral
End date: 2006-06-08
Omeprazole
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Micardis
Administration route: Oral
Indication: Essential Hypertension
End date: 2006-06-08
Nitroderm
Administration route: Topical
End date: 2006-06-18
Hemigoxine Nativelle
Administration route: Oral
End date: 2006-06-08
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a health professional (non-physician/pharmacist) from France on 2007-04-24
Patient: 83 year old male
Adverse reactions / side effects: Hyperthyroidism
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Temgesic
Administration route: Oral
Kardegic
Administration route: Oral
End date: 2006-06-08
Omeprazole
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Micardis
Administration route: Oral
Indication: Essential Hypertension
End date: 2006-06-08
Nitroderm
Administration route: Topical
End date: 2006-06-18
Hemigoxine Nativelle
Administration route: Oral
End date: 2006-06-08
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a health professional (non-physician/pharmacist) from France on 2007-04-24
Patient: 83 year old male
Adverse reactions / side effects: Hyperthyroidism
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Temgesic
Administration route: Oral
Kardegic
Administration route: Oral
End date: 2006-06-08
Omeprazole
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Micardis
Administration route: Oral
Indication: Essential Hypertension
End date: 2006-06-08
Nitroderm
Administration route: Topical
End date: 2006-06-18
Hemigoxine Nativelle
Administration route: Oral
End date: 2006-06-08
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a health professional (non-physician/pharmacist) from France on 2007-04-20
Patient: 83 year old male
Adverse reactions / side effects: Hyperthyroidism
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Temgesic
Administration route: Oral
Kardegic
Administration route: Oral
End date: 2006-06-08
Omeprazole
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Micardis
Administration route: Oral
Indication: Essential Hypertension
End date: 2006-06-08
Nitroderm
Administration route: Topical
End date: 2006-06-18
Hemigoxine Nativelle
Administration route: Oral
End date: 2006-06-08
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a individual with unspecified qualification from France on 2007-02-23
Patient: 83 year old male
Adverse reactions / side effects: Dysphagia, Blood Thyroid Stimulating Hormone Decreased, Cardiomyopathy, Gastrointestinal Tube Insertion, Iodine Uptake Increased, Haemangioma, Hyperthyroidism, Thyroid Neoplasm
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Kardegic
Dosage: 1 df, qd
Administration route: Oral
Indication: Cardiomyopathy
End date: 2006-06-08
Omeprazole
Dosage: 20 mg, qd
Administration route: Oral
Temgesic
Dosage: 0.2 mg, qd
Administration route: Oral
Indication: Brain Neoplasm
Micardis
Dosage: 1 df, qd
Administration route: Oral
Indication: Hypertension
End date: 2006-06-08
Hemigoxine Nativelle
Administration route: Oral
Indication: Cardiomyopathy
End date: 2006-06-08
Nitroderm
Dosage: 1 df, qd
Indication: Cardiomyopathy
End date: 2006-06-18
Other drugs received by patient: NEO-Mercazole TAB
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a individual with unspecified qualification from France on 2007-02-22
Patient: 83 year old male
Adverse reactions / side effects: Dysphagia, Blood Thyroid Stimulating Hormone Decreased, Cardiomyopathy, Gastrointestinal Tube Insertion, Iodine Uptake Increased, Haemangioma, Hyperthyroidism, Thyroid Neoplasm
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Kardegic
Dosage: 1 df, qd
Administration route: Oral
Indication: Cardiomyopathy
End date: 2006-06-08
Omeprazole
Dosage: 20 mg, qd
Administration route: Oral
Temgesic
Dosage: 0.2 mg, qd
Administration route: Oral
Indication: Brain Neoplasm
Micardis
Dosage: 1 df, qd
Administration route: Oral
Indication: Hypertension
End date: 2006-06-08
Hemigoxine Nativelle
Administration route: Oral
Indication: Cardiomyopathy
End date: 2006-06-08
Nitroderm
Dosage: 1 df, qd
Indication: Cardiomyopathy
End date: 2006-06-18
Other drugs received by patient: NEO-Mercazole TAB
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a health professional (non-physician/pharmacist) from France on 2007-02-15
Patient: 83 year old male
Adverse reactions / side effects: Hyperthyroidism
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Temgesic
Administration route: Oral
Kardegic
Administration route: Oral
End date: 2006-06-08
Mopral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Micardis
Administration route: Oral
Indication: Essential Hypertension
End date: 2006-06-08
Nitroderm
Administration route: Topical
End date: 2006-06-18
Hemigoxine Nativelle
Administration route: Oral
End date: 2006-06-08
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a physician from France on 2007-02-12
Patient: 83 year old male
Adverse reactions / side effects: Congestive Cardiomyopathy, Hyperthyroidism
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Micardis (Telmisartan)
Other drugs received by patient: Aspirin; Omeprazole; Temgesic; Nitroderm; Hemigoxine Nativelle
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a individual with unspecified qualification from France on 2007-01-18
Patient: 83 year old male
Adverse reactions / side effects: Dysphagia, Haemangioma, Blood Thyroid Stimulating Hormone Decreased, Hyperthyroidism, Thyroid Neoplasm, Gastrointestinal Tube Insertion, Iodine Uptake Increased
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Aspirin
Dosage: 1 df, qd
Administration route: Oral
Indication: Cardiomyopathy
End date: 2006-06-08
Omeprazole
Dosage: 20 mg, qd
Administration route: Oral
Temgesic
Dosage: 0.2 mg, qd
Administration route: Oral
Indication: Brain Neoplasm
Micardis
Dosage: 1 df, qd
Administration route: Oral
Indication: Hypertension
End date: 2006-06-08
Hemigoxine Nativelle
Administration route: Oral
Indication: Cardiomyopathy
End date: 2006-06-08
Nitroderm
Dosage: 1 df, qd
Indication: Cardiomyopathy
End date: 2006-06-18
Other drugs received by patient: NEO-Mercazole TAB
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a physician from France on 2007-01-11
Patient: 83 year old male
Adverse reactions / side effects: Congestive Cardiomyopathy, Hyperthyroidism
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Micardis (Telmisartan)
Other drugs received by patient: Aspirin; Omeprazole; Temgesic; Nitroderm; Hemigoxine Nativelle
|
